Lexicon Genetics Licenses Knockout Mouse Technology to Lilly | GenomeWeb

NEW York, Nov. 16 – Lexicon Genetics has sublicensed aspects of its proprietary knockout mouse technology to Eli Lilly, the company announced Thursday.

The non-exclusive license covers the positive-negative selection and isogenic DNA technologies that Lexicon has licensed from academic researchers for its proprietary mouse gene function validation experiments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.